n Southern African Journal of HIV Medicine - The risks of concurrent treatment with tenofovir and aminoglycosides in patients with HIV-associated tuberculosis : case study - HIV and the kidneys
|Article Title||The risks of concurrent treatment with tenofovir and aminoglycosides in patients with HIV-associated tuberculosis : case study - HIV and the kidneys|
|Journal||Southern African Journal of HIV Medicine|
|Author||Chris Kenyon, Nicci Wearne, Rosie Burton and Graeme Meintjes|
|Publication Date||Apr 2011|
|Pages||43 - 45|
|Keyword(s)||Imperial College London and University of Cape Town|
The South African public sector antiretroviral treatment (ART) guidelines have recently been changed to include tenofovir in the first-line regimen. Injectable drugs from the aminoglycoside class are part of the intensive phase of regimen 2 tuberculosis (TB) treatment and the multidrug-resistant (MDR) TB treatment regimen in the South African TB programme. We wish to draw the attention of clinicians managing patients with HIV-associated TB to the potential dangers of concurrent administration of these drugs. We present two illustrative cases.
Article metrics loading...